Related by context. Frequent words. (Click for all words.) 73 Initiates Phase II 71 Presents Positive 71 Completes Patient Enrollment 71 Commences Phase 70 Completes Enrollment 69 Meets Primary Endpoint 69 Receives Orphan Drug Designation 66 Initiate Phase 66 Initiates Phase 65 Study Evaluating 65 VEGFR2 inhibitor 65 2 methoxyestradiol 65 Pivotal Phase 64 Pivotal Phase III 64 Signs License Agreement 64 Locteron ® 64 Joins OTCQX 64 Inc Therapeutic Competitors 63 Phase III Clinical Trial 63 Phase Ib clinical trials 63 Clinical Trial Results 63 oncolytic virus therapies 63 Phase IIb trials 63 MKC# 62 II Clinical Trial 62 Shareholders Approve Acquisition 62 Secures Additional 62 Receives Positive 62 signal detection CTSD 62 Metastatic Melanoma 62 Guides FY# Quick Facts 61 Phase III Trial 61 Guides FY# Update 61 fibrosis IPF 61 Declares Dividend Quick Facts 61 Panzem R 61 initiate Phase IIb 61 IIa trial 61 Panzem R NCD 61 Phase Ib II 61 Therapeutic Competitors 61 Pivotal Study 61 Recombinant Human 61 Expands Portfolio 61 phenylalanine ammonia lyase 61 phase IIa clinical 61 Thiarabine 61 FDA Accepts 60 ThermoDox R 60 topical non steroidal 60 Pivotal Trial 60 Transcept Pharmaceuticals 60 refractory chronic lymphocytic 60 Attracting Bullish Investors 60 Enters Into Strategic 60 ® bortezomib 60 Kinase Inhibitor 60 novel orally administered 60 developing Zerenex TM 59 Inc. NASDAQ MBLX 59 Phase 2a clinical 59 GVAX R 59 multi kinase inhibitor 59 Inhalation Aerosol 59 gets USFDA nod 59 NASDAQ CRXL 59 immatics 59 Crucell NV NYSE Euronext 59 addressing idiopathic pulmonary 59 IIROC Halt 59 JAK1 59 Announces Additions 59 Tesetaxel 59 Onalta 59 Phase 1b clinical 59 Phase 2b clinical 59 huC# DM4 59 epothilones 59 sodium Injection 59 cutaneous T 59 confirmatory Phase III 59 phase IIb clinical 58 Inhalation Solution 58 FFO Rises 58 liposomal formulation 58 PSMA ADC 58 Phase Ib clinical 58 ANYARA 58 Xanafide 58 Idera Pharmaceuticals 58 candidates bavituximab 58 Genasense ® oblimersen 58 produces Chrysler Jeep 58 Sapacitabine 58 Kuvan R 58 Nasdaq ENMD 58 registrational trial 58 histone deacetylase HDAC inhibitor 58 Announces Immediate Availability 58 R bortezomib 58 inhaled formulation